Abstract
This chapter considers ethical and social issues arising from applying advances in nanotechnologies to medicine, and more briefly to enhancing the human body. While these are usually enabling technologies, they already embody values and imply trajectories for future medicine which raise important questions. In enabling a move to pre-symptomatic medicine, nano-diagnostics may revolutionise some treatments, but also pose problems. Do we want advanced warning of an untreatable disease? How early in life should we begin to take preventative medication if the onset of a treatable condition is only a probability? Are we all already ‘ill’? Handling, interpreting and counselling the increased information will be important. Nanoscale remote monitoring devices present many practical advantages to the elderly and chronically sick but at the cost of a degree of intrusion by a third party, and a shift of responsibility to the patient and the carer, which may not always be welcome. Targeted drug delivery offers many improvements but also with uncertainties about nanoparticles, side effects and patient variability. Theranostic devices which combine monitoring and therapeutic action still need human controls. In regenerative medicine, nano-scaffolds could enable tissue repair and simple replacements, but major organ constructs, if ever feasible, would need careful ethical assessment. Should nano-enabled interventions in the body become the norm, or used only for particular conditions? There may also be pressure to use devices for other than medical reasons. Human values are needed to modulate engineering logic. Faced with risk and uncertainties, how do we decide when to proceed with a nanomedical intervention, or to exercise precaution? The use of nanotechnologies to enhance the human body are discussed briefly. Important questions include how far we regard the body as ‘given’ or alterable; can we distinguish between medical interventions and enhancements; risks; worsening the rich-poor divide; whether such functional ‘improvements’ really enhance human life when viewed holistically, or when set against more pressing problems facing societies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
CLINAM (2014) European foundation for clinical nanomedicine. www.clinam.org. Accessed
Mnyusiwalla A, Daar AS, Singer PA (2003) Mind the gap: science and ethics in nanotechnology, nanotechnology. Nanotechnology 14:R9–R13
Bruce DM (2006a) Ethical and social issues in nanobiotechnologies. EMBO Rep 7:754–758
Bruce DM (2006b) Nano2Life ethics: a scoping paper on ethical and social issues in nanobiotechnologies. In: Ach JS, Siep L (eds) Nano-bio-ethics: ethical dimensions of nanobiotechnology. Lit Verlag, Münster, pp 63–83
Bennett DJ, Schuurbiers D (2005) Nanobiotechnology: responsible action on issues in society and ethics (NANOBIO-RAISE). In: Nanotech 2005: technical proceedings of the 2005 NSTI nanotechnology conference and trade show, vol 2, pp. 765–768. http://www.nsti.org/publications/Nanotech/2005/pdf/402.pdf. Accessed 17 Jan 2013
NanoMed Round Table (2011) NanoMed round table: A report on the nanomedicine environment, http://www.philosophie.tu-darmstadt.de/media/institut_fuer_philosophie/diesunddas/nordmann/nanomed.pdf. Accessed 17 and 18 Jan 2013
ObservatoryNANO (2010) ObservatoryNANO 2nd annual report on ethical and societal aspects of nanotechnology, http://www.observatorynano.eu/project/filesystem/files/NanobioethicsApril2010.pdf. 27 Sept 2014
DEEPEN (2009) Deepening ethical engagement and participation in emerging nanotechnologies. http://www.geography.dur.ac.uk/Projects/Default.aspx?alias=www.geography.dur.ac.uk/projects/deepen. Accessed 29 July 2013
EGE (2007) Ethical aspects of nanomedicine, Opinion 21 of the European group on ethics in science and new technologies to the European Union, 17 Jan 2007. European Commission, Brussels. http://ec.europa.eu/bepa/european-group-ethics/docs/publications/opinion_21_nano_en.pdf. Accessed 18 Jan 2013
ETC Group (2003) The big down: Atomtech – technologies converging at the nano-scale. ETC Group, Winnipeg
The Royal Society, The Royal Academy of Engineering (2004) Nanoscience and nanotechnologies: opportunities and uncertainties. The Royal Society, London
European Commission (2005) Eurobarometer 63: public opinion in the European Union, European Commission, Brussels. http://ec.europa.eu/public_opinion/archives/eb_arch_en.htm. Accessed 29 July 2013
Gavelin K, Wilson R, Doubleday R (2007) Democratic nanotechnologies? The final report of the Nanotechnology Engagement group. Involve, London. http://www.involve.org.uk/neg. Accessed 18 Jan 2013
Grobe A, Rissanen M, Funda P, de Beer J and Jonas U (2012) Nanotechnologies from the consumers’ point of view: what consumers know and what they would like to know. Stiftung Risiko Dialog, St Gallen. http://www.risiko-dialog.ch/images/RD-Media/PDF/Themen/Nanotechnologie/Konsumentenstudie_Nano_2011_final.pdf (in German). English summary, http://www.risiko-dialog.ch/images/RD-Media/PDF/Themen/Nanotechnologie/Consumerstudy_Nano_EN.pdf. Accessed 18 Jan 2013
Rathenau Instituut (2011) Governance of nanotechnology in the Netherlands – Informing and engaging in different social spheres. Rathenau Instituut, Den Haag, The Netherlands. http://www.rathenau.nl/en/publications/publication/governance-of-nanotechnology-in-the-netherlands-informing-and-engaging-in-different-social-spher.html. Accessed 18 Jan 2013
DEFRA (2011) Nanotechnologies stakeholder group, 2005–2010. UK Department for the Environment, Food and Rural affairs, London. http://archive.defra.gov.uk/environment/quality/nanotech/research.htm. Accessed 29 July 2013
Friends of the Earth (2006) Nanomaterials, sunscreens and cosmetics. http://nano.foe.org.au/sites/default/files/FoEA%20nano%20cosmetics%20report%202MB.pdf. Accessed 18 Jan 2013
Friends of the Earth (2011) Nano-silver: policy failure puts public health at risk. http://nano.foe.org.au/sites/default/files/Nano-silver_2011%20Aus%20v2%20web.pdf. Accessed 18 Jan 2013
Phillips L (2012) Nanotechnology: armed resistance. Nature 488:576–579, 30 Aug 2012, http://www.nature.com/news/nanotechnology-armed-resistance-1.11287. Accessed 18 Jan 2013
Bhattachary D, Stockley R, Hunter A (2008) Nanotechnology for healthcare, prepared for the Engineering and Physical Sciences Research Council, July 2008. Engineering and Physical Sciences Research Council, Swindon
Davies S, Macnaghten P, Kearnes M (eds) (2009) Reconfiguring responsibility: lessons for public policy (Part 1 of the report on Deepening debate on nanotechnology). Durham University, Durham
Ferrari A, Nordmann A (eds) (2009) Reconfiguring responsibility: lessons for nanoethics (Part 2 of the report on Deepening debate on nanotechnology). Durham University, Durham
General Medical Council (2008) Consent: patients and doctors making decisions together. UK General Medical Council, Manchester. http://www.gmc-uk.org/static/documents/content/Consent_-_English_0911.pdf. Accessed 18 Jan 2013
Frodshamon G (2012) Insurance will continue to be unaffected by predictive genetic tests, says Government. BioNews 663:2 July 2012. http://www.bionews.org.uk/page_154877.asp. Accessed 18 Jan 2013
DoH (2007) See for example, Genetics and Insurance Committee, Sixth report from January 2007 to December 2007. UK Department of Health, London. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_084686.pdf. Accessed 18 Jan 2013
Roco MC, Bainbridge WS (eds) (2002) Converging technologies for improving human performances, US National Science Foundation report. US National Science Foundation, Washington, DC
Nordmann A (ed) (2004) Converging technologies and the natural, social and cultural world, report of a European Commission expert group. European Commission, Brussels
Academy of Medical Sciences (2012) Joint academies project on human enhancement and the future of work. Academy of Medical Sciences, London. http://www.acmedsci.ac.uk/p47prid102.html. Accessed 18 Jan 2013
Rathenau Instituut (2012) Human enhancement. Rathenau Instituut, Den Haag, The Netherlands. http://www.rathenau.nl/en/publications/publication/human-enhancement-1.html. Accessed 18 Jan 2013
Savalescu J, Bostrom N (2009) Human enhancement. OUP, Oxford
ETHENTECH (2012) Ethics of enhancement technologies. EC FP7 ETHENTECH project: Final report to the European Commission, 2012, (in press)
Bruce DM (ed) (2007) Human enhancement: ethical reflections on emerging nanobio-technologies, Report of an expert working group of the EC NanoBio-Raise programme. http://www.edinethics.co.uk/nano/enhancement.html
Ferrari A, Coenen C, Grunwald A (2012) Visions and ethics in current discourse on human enhancement. Nanoethics 6:215–229
Nordmann A (2007) If and then: a critique of speculative nanoethics. NanoEthics 1:31–46
Meulen R, Savulescu J, Kahane G (eds) (2011) Enhancing human capacities, Wiley-Blackwell, Oxford. This collection was derived in part from the EC FP6 Science and society project ENHANCE – Enhancing human capacities: ethics, regulation and European policy. http://www.euprojekt.su.se/index.php/kb_83/io_1278/io.html. Accessed 18 Jan 2013
Conference of European Churches (2009) Human enhancement – A discussion document. Conference of European churches (CEC), Strasbourg. http://csc.ceceurope.org/fileadmin/filer/csc/Ethics_Biotechnology/Human_enhancement_final_March_10.pdf. Accessed 18 Jan 2013
Committee of European Catholic Bishops Conferences (2009) On the prospects for improvement of the human being (human enhancement) 25 May 2009, Committee of European catholic bishops conferences (COMECE). Brussels
Bruce D, Bruce A (eds) (1998) Engineering genesis. Earthscan, London, pp 113–114
Bruce DM, Walker P (2012) Democs games on human enhancement played to end June 2012 within the ETHENTECH Project. Submitted to the European Commission, (in press)
Holm S, McNamee M (2011) Physical enhancement: what baseline, whose judgement? In: Enhancing human capacities. Wiley-Blackwell, Oxford, pp 291–303
Jerome JK (1889) Three men in a boat. Penguin, London, pp 7–10
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bruce, D. (2014). Ethical Implications of Nanomedicine: Implications of Imagining New Futures for Medicine. In: Ge, Y., Li, S., Wang, S., Moore, R. (eds) Nanomedicine. Nanostructure Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2140-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2140-5_12
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2139-9
Online ISBN: 978-1-4614-2140-5
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)